SLC16A1 and cancer: Indeed, we provide evidence that [18F]-FLac is actively taken up and retained by oxidative cancer cells that consume lactate in vitro, and accumulates in tumors and tissues known to consume lactate in vivo, which is efficiently prevented by the pharmacological inhibition of inward lactate transporter MCT1.